Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHRN | ATAI |
|---|---|---|
| Price | $19.11 | $7.35 |
| Change today | ▲ 2.74% | ▲ 0.00% |
| Market cap | $2.78B | $2.73B |
| Return, 3 months | +9.1% | – |
| Return, year to date | +121.2% | – |
| Return, 1 year | +248.1% | – |
| P/E (TTM) | -53.1 | -2.6 |
| P/B | 15.5 | 15.4 |
| P/E percentile vs own 5y | 3rd | 58th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +67.5% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 43 | 54 |
| 30-day volatility | 84.3% | 9.4% |
| Max drawdown, 1 year | -40.4% | -2.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
